About Diabetic Eye Disease Devices
Diabetes eye diseases consist of a group of eye-related conditions that affect individuals with diabetes. The conditions include diabetic macular edema (DME), diabetic retinopathy, glaucoma, and cataract. Diabetes is the leading cause of eye diseases and can cause severe vision loss or blindness. These eye diseases are widely treated with laser surgery.
Technavios analysts forecast the global diabetic eye disease devices market to grow at a CAGR of 8.81% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global diabetic eye disease devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of diabetic eye disease devices.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Diabetic Eye Disease Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alcon Inc.
• Ellex Medical Lasers Ltd.
• IRIDEX Corp.
• Synergetics USA Inc.
• Topcon Corp.
Other prominent vendors
• Abbott Medical Optics
• Bausch & Lomb
• Carl Zeiss Meditec
• Lumenis
• Meridian
• NIDEK
• Quantel
• Rhein Medical
Market driver
• Rise in older population
• For a full, detailed list, view our report
Market challenge
• Availability of substitutes for retinal surgeries
• For a full, detailed list, view our report
Market trend
• Advances in laser technology
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Disease eye diseases: An overview
Diabetic retinopathy
DME
Cataract
Economic burden of ophthalmic diseases
Photocoagulation ophthalmic laser used for treatment of diabetic retinopathy
Glaucoma
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Market segmentation by product type
Market segmentation of global diabetic eye disease devices market by product type
Global vitrectomy packs market
Global retinal lasers market
Global vitrectomy machines market
PART 08: Market segmentation by technology
Global diabetic eye disease devices market by technology
PART 09: Geographical segmentation
Diabetic eye disease devices market in Americas
Diabetic eye disease devices market in EMEA
Diabetic eye disease devices market in APAC
PART 10: Market drivers
Increased prevalence of diabetes
Rise in older population
Untapped market in emerging countries
Growing number of MI surgeries
PART 11: Impact of drivers
PART 12: Market challenges
Potential risk of complications
High cost of lasers
Availability of substitutes for retinal surgeries
Limited public awareness
PART 13: Impact of drivers and challenges
PART 14: Market trends
Advances in laser technology
Increased adoption of valved cannulas
Emerging laser vitreolysis technology
Increase in adoption of vitrectomy machines
PART 15: Vendor landscape
Competitive scenario
Key vendor analysis
Alcon
Ellex
IRIDEX
Synergetics USA
Topcon
Other prominent vendors
PART 16: Appendix
List of abbreviations
PART 17: Explore Technavio
?
Exhibit 01: Product offerings
Exhibit 02: Diabetic eye diseases
Exhibit 03: Development of diabetic retinopathy
Exhibit 04: Classification of diabetic retinopathy
Exhibit 05: Types of glaucoma
Exhibit 06: Global diabetic eye disease devices market 2015-2020 ($ millions)
Exhibit 07: Five forces analysis
Exhibit 08: Global diabetic eye disease devices market by product type 2015
Exhibit 09: Global vitrectomy packs market 2015-2020 ($ millions)
Exhibit 10: Global retinal lasers market 2015-2020 ($ millions)
Exhibit 11: Global vitrectomy machines market 2015-2020 ($ millions)
Exhibit 12: Global diabetic eye disease devices market by product type 2015-2020 ($ millions)
Exhibit 13: Global diabetic eye disease devices market by product type 2015-2020
Exhibit 14: Global diabetic eye disease devices market by technology 2015
Exhibit 15: Global diabetic eye disease devices market by geography 2015
Exhibit 16: Diabetic eye disease devices market in Americas 2015-2020 ($ millions)
Exhibit 17: Diabetic eye disease devices market in EMEA 2015-2020 ($ millions)
Exhibit 18: Diabetic eye disease devices market in APAC 2015-2020 ($ millions)
Exhibit 19: Global diabetic eye disease devices market by product type 2015-2020 ($ millions)
Exhibit 20: Global diabetic eye disease devices market by product type 2015-2020
Exhibit 21: Population aged 60 years and over: World, developed, and developing regions 1950-2050 (millions)
Exhibit 22: Impact of drivers
Exhibit 23: Impact of drivers and challenges
Exhibit 24: Product portfolio matrix of vendors
Exhibit 25: Alcon: Product portfolio
Exhibit 26: Alcon: Key takeaways
Exhibit 27: Ellex Medical Lasers: Product portfolio
Exhibit 28: Ellex Medical Lasers: Distributors segment by revenue 2013-2015 ($ millions)
Exhibit 29: Ellex Medical Lasers: Direct segment by revenue 2013-2015 ($ millions)
Exhibit 30: Ellex Medical Lasers: Key takeaways
Exhibit 31: IRDIEX: Product portfolio
Exhibit 32: IRIDEX: Ophthalmology segment by revenue 2012-2014 ($ millions)
Exhibit 33: IRIDEX: Key takeaways
Exhibit 34: Synergetics USA: Product portfolio
Exhibit 35: Synergetics USA: Ophthalmic segment by revenue 2013-2015 ($ millions)
Exhibit 36: Synergetics USA: Key takeaways
Exhibit 37: Topcon: Product portfolio
Exhibit 38: opcon: Eye care segment by revenue 2013-2015 ($ millions)
Exhibit 39: Topcon: Key takeaways
Exhibit 40: Other prominent vendors
